CAPRICOR THERAPEUTICS, INC.CAPR

Market cap

$1.2B

P/E ratio

	2011/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	1	2	8	6	3	7	5	4	33	35	10	15	11
Marketable securities, current	-	326,494	-	8	13	8	3	6	-	-	32	25	140
Total cash & short-term investments	1	2	8	14	16	15	8	10	33	35	41	39	152
Total current assets	1	4	12	14	18	16	8	11	34	36	43	51	163
Property, plant and equipment, net	9,744	74,187	229,455	318,566	435,336	372,096	574,206	442,806	850,847	2	5	6	6
Total non-current assets	61,682	2	2	2	639,015	561,113	775,766	568,909	941,713	5	7	8	7
Total assets	1	6	14	16	19	16	9	11	35	41	50	59	170
Accounts payable	437,837	-	-	-	-	-	-	-	-	-	-	-	-
Total current liabilities	541,447	2	6	7	5	2	1	897,992	3	4	24	31	21
Total non-current liabilities	-	4	14	11	18	3	3	3	3	6	15	5	4
Total liabilities	-	6	20	17	23	5	5	4	6	10	38	36	25
Common stock and paid-in capital	46	16	11,707	16,255	21,399	26,271	3,138	5,227	20,577	24,185	25,241	31,148	45,582
Retained earnings	-44,814,980	-	-22,315,127	-35,172,466	-53,979,242	-51,547,819	-66,738,914	-74,380,731	-88,037,759	-108,060,279	-137,079,811	-159,367,353	-200
Stockholders' equity	830,723	-534,882	-6,248,723	-1,031,774	-4,003,154	11	5	7	28	31	12	23	145